BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23393562)

  • 1. Nanopore analysis of wild-type and mutant prion protein (PrP(C)): single molecule discrimination and PrP(C) kinetics.
    Jetha NN; Semenchenko V; Wishart DS; Cashman NR; Marziali A
    PLoS One; 2013; 8(2):e54982. PubMed ID: 23393562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion proteins with pathogenic and protective mutations show similar structure and dynamics.
    Bae SH; Legname G; Serban A; Prusiner SB; Wright PE; Dyson HJ
    Biochemistry; 2009 Sep; 48(34):8120-8. PubMed ID: 19618915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases.
    Lorenz H; Windl O; Kretzschmar HA
    J Biol Chem; 2002 Mar; 277(10):8508-16. PubMed ID: 11756421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early structural features in mammalian prion conformation conversion.
    Legname G
    Prion; 2012; 6(1):37-9. PubMed ID: 22453176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic origin of the abnormal prion protein isoform in familial prion diseases.
    Chen SG; Parchi P; Brown P; Capellari S; Zou W; Cochran EJ; Vnencak-Jones CL; Julien J; Vital C; Mikol J; Lugaresi E; Autilio-Gambetti L; Gambetti P
    Nat Med; 1997 Sep; 3(9):1009-15. PubMed ID: 9288728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective processing and metabolism of disease-causing mutant prion proteins.
    Ashok A; Hegde RS
    PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unfolded state of the murine prion protein and properties of single-point mutants related to human prion diseases.
    Gerum C; Schlepckow K; Schwalbe H
    J Mol Biol; 2010 Aug; 401(1):7-12. PubMed ID: 20541558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells.
    Lehmann S; Daude N; Harris DA
    Brain Res Mol Brain Res; 1997 Dec; 52(1):139-45. PubMed ID: 9450686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
    Elmallah MI; Borgmeyer U; Betzel C; Redecke L
    Prion; 2013; 7(5):404-11. PubMed ID: 24121542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and genetics of prion diseases.
    Prusiner SB
    Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for mutant and wild-type prion protein misfolding in vitro.
    Noble GP; Walsh DJ; Miller MB; Jackson WS; Supattapone S
    Biochemistry; 2015 Feb; 54(5):1180-7. PubMed ID: 25584902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance.
    Gauczynski S; Krasemann S; Bodemer W; Weiss S
    J Cell Sci; 2002 Nov; 115(Pt 21):4025-36. PubMed ID: 12356908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
    Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
    J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.